Smartphone-Based Dietary Support for Obesity
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications, but you cannot participate if you are currently taking weight loss medication.
What data supports the effectiveness of the treatment Smartphone-Based Dietary Support for Obesity?
Research shows that mobile eHealth interventions, which include smartphone-based approaches, can effectively promote weight loss and maintenance by encouraging behavior changes. Additionally, tailored informational interventions and self-management education have been successful in helping individuals lose weight and improve dietary habits.12345
Is smartphone-based dietary support for obesity safe for humans?
The research on mobile and web-based interventions for obesity, which includes smartphone-based dietary support, generally shows positive effects on weight management and dietary habits. While the studies focus on effectiveness, they do not report any significant safety concerns, suggesting these interventions are generally safe for human use.35678
How is the Smartphone-Based Dietary Support for Obesity treatment different from other obesity treatments?
This treatment is unique because it uses a smartphone app to provide personalized dietary support, combining education, motivation, and self-monitoring to help people manage their weight. It emphasizes self-regulation and tailored advice, which has been shown to be more effective than non-tailored interventions in supporting weight loss.568910
What is the purpose of this trial?
This project targets dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment, which is a recommended first-line intervention for cardiovascular disease. The investigators propose to conduct a micro-randomized trial (MRT) to empirically optimize a smartphone-based just-in-time adaptive intervention (JITAI) that monitors risk and intervenes on lapses as needed. By evaluating the immediate, proximal effect of four theory-driven interventions on lapse behavior, the project will: (a) produce a scalable, finalized JITAI that has the greatest potential to show clear clinical impact in future trials; and (b) inform the development of more sophisticated theoretical models of adherence behavior more broadly. Therefore, this study has three goals. First the investigators aim to compare the effects of delivering any intervention to no intervention on the occurrence of lapse. Second, the investigators aim to compare the effects of specific theory-driven interventions to one another to determine which ones are best for preventing lapses. Within this second aim, the investigators also aim to examine other factors that may influence the effectiveness of interventions (e.g., time, location). Lastly, the investigators will use the data from this MRT to customize intervention delivery in future versions of this JITAIPatients will be recruited through various methods including advertisements in local media, targeted online advertising, advertisements in medical and minority communities, and direct mailers. All participants will receive a well-established 3-month online obesity treatment program, with 3 months of no-treatment follow-up. In conjunction, they will use a smartphone-based JITAI consisting of: 1) repeated daily surveys assess lapses and relevant triggers; 2) a machine learning algorithm that uses information from the surveys to determine real-time lapse risk; \& 3) interventions to counter lapse risk. When an individual is at risk for lapsing she will be randomly assigned to no intervention, a generic risk alert, or one of 4 theory-driven interventions with interactive skills training. The outcome of interest will be the occurrence (or lack thereof) of dietary lapse, as measured both subjectively (i.e., reported by the participant in the daily surveys) and objectively (i.e., via wrist-based intake monitoring), in the hours following randomization initiated by heightened lapse risk.
Eligibility Criteria
This trial is for adults aged 18-70 with a BMI of 25-50 and at least one cardiovascular risk factor like prediabetes, type 2 diabetes, high cholesterol, or hypertension. They must be able to walk two blocks without stopping and not be in another weight loss program or have conditions that affect study participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline questionnaires and self-reported logs of dietary intake and ecological momentary assessments (EMA) for 1 week before the baseline assessment.
Treatment
Participants receive 3 months of online behavioral obesity treatment (BOT) and use the JITAI system to monitor and intervene on dietary lapses.
Follow-up
Participants continue using the JITAI system without the behavioral obesity treatment for an additional 3 months.
Treatment Details
Interventions
- Enhanced Education
- Generic Risk Alert (Active Comparator)
- Motivation
- Online Behavioral Obesity Treatment
- Self-Efficacy
- Self-Regulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator